Abstract
A method has been described for the chemical modification of human C'2 which results in a pronounced enhancement of its hemolytic activity and a marked increase in the stability of the intermediate complex EAC'1a,4,2a prepared with the modified C'2. Both effects are fully explained by the observed increase in activity and stability of the C'3 converting enzyme, C'4,2a, following its generation with modified C'2. Evidence has been presented in support of the hypothesis that the modification resulting from treatment of C'2 with a critical concentration of iodine consists of oxidation of one or more sulfhydryl group within the molecule.
Full Text
The Full Text of this article is available as a PDF (692.0 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BECKER E. L. Concerning the mechanism of complement action. V. The early steps in immune hemolysis. J Immunol. 1960 Mar;84:299–308. [PubMed] [Google Scholar]
- CUNNINGHAM L. W., NUENKE B. J. Analysis of modified beta-lactoglobulins and ovalbumins prepared from the sulfenyl iodine intermediates. J Biol Chem. 1960 Jun;235:1711–1715. [PubMed] [Google Scholar]
- HAINES A. L., LEPOW I. H. STUDIES ON HUMAN C'1-ESTERASE. I. PURIFICATION AND ENZYMATIC PROPERTIES. J Immunol. 1964 Mar;92:456–467. [PubMed] [Google Scholar]
- HIRD F. J., YATES J. R. The oxidation of protein thiol groups by iodate, bromate and persulphate. Biochem J. 1961 Sep;80:612–616. doi: 10.1042/bj0800612. [DOI] [PMC free article] [PubMed] [Google Scholar]
- HUGHES W. L. The chemistry of iodination. Ann N Y Acad Sci. 1957 Aug 30;70(1):3–18. doi: 10.1111/j.1749-6632.1957.tb35373.x. [DOI] [PubMed] [Google Scholar]
- LEON M. A. COMPLEMENT: INACTIVATION OF SECOND COMPONENT BY P-HYDROXYMERCURIBENZOATE. Science. 1965 Feb 26;147(3661):1034–1035. doi: 10.1126/science.147.3661.1034. [DOI] [PubMed] [Google Scholar]
- LEPOW I. H., NAFF G. B., TODD E. W., PENSKY J., HINZ C. F. Chromatographic resolution of the first component of human complement into three activities. J Exp Med. 1963 Jun 1;117:983–1008. doi: 10.1084/jem.117.6.983. [DOI] [PMC free article] [PubMed] [Google Scholar]
- MAYER M. M., LEVINE L., RAPP H. J., MARUCCI A. A. Kinetic studies on immune hemolysis. VII. Decay of EAC'1, 4, 2, fixation of C'3, and other factors influencing the hemolytic action of complement. J Immunol. 1954 Dec;73(6):443–454. [PubMed] [Google Scholar]
- MUELLER-EBERHARD H. J., BIRO C. E. ISOLATION AND DESCRIPTION OF THE FOURTH COMPONENT OF HUMAN COMPLEMENT. J Exp Med. 1963 Sep 1;118:447–466. doi: 10.1084/jem.118.3.447. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Müller-Eberhard H. J., Polley M. J., Calcott M. A. Formation and functional significance of a molecular complex derived from the second and the fourth component of human complement. J Exp Med. 1967 Feb 1;125(2):359–380. doi: 10.1084/jem.125.2.359. [DOI] [PMC free article] [PubMed] [Google Scholar]
- NILSSON U. R., MUELLER-EBERHARD H. J. ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT. J Exp Med. 1965 Aug 1;122:277–298. doi: 10.1084/jem.122.2.277. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stroud R. M., Mayer M. M., Miller J. A., McKenzie A. T. C'2ad, an inactive derivative of C'2 released during decay of EAC'4,2a. Immunochemistry. 1966 May;3(3):163–176. doi: 10.1016/0019-2791(66)90182-0. [DOI] [PubMed] [Google Scholar]
- VALLEE B. L. ACTIVE CENTER OF CARBOXYPEPTIDASE A. Fed Proc. 1964 Jan-Feb;23:8–17. [PubMed] [Google Scholar]
- VALLEE B. L., RIORDAN J. F., COLEMAN J. E. Carboxypeptidase A: approaches to the chemical nature of the active center and the mechanisms of action. Proc Natl Acad Sci U S A. 1963 Jan 15;49:109–116. doi: 10.1073/pnas.49.1.109. [DOI] [PMC free article] [PubMed] [Google Scholar]